| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges | International Journal of Antimicrobial Agents | 2020 | 4,326 |
| 2 | Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial | International Journal of Antimicrobial Agents | 2020 | 4,083 |
| 3 | Antimicrobial activity of flavonoids | International Journal of Antimicrobial Agents | 2005 | 3,055 |
| 4 | Antibiotic resistance of bacterial biofilms | International Journal of Antimicrobial Agents | 2010 | 2,886 |
| 5 | Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality | International Journal of Antimicrobial Agents | 2020 | 1,504 |
| 6 | Characterisation of copper oxide nanoparticles for antimicrobial applications | International Journal of Antimicrobial Agents | 2009 | 1,274 |
| 7 | Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. | International Journal of Antimicrobial Agents | 2006 | 946 |
| 8 | Recent advances in understanding the antibacterial properties of flavonoids | International Journal of Antimicrobial Agents | 2011 | 917 |
| 9 | Antimicrobial peptides: premises and promises | International Journal of Antimicrobial Agents | 2004 | 872 |
| 10 | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? | International Journal of Antimicrobial Agents | 2020 | 866 |
| 11 | Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence | International Journal of Antimicrobial Agents | 2020 | 852 |
| 12 | Coronavirus disease 2019 (COVID-19): current status and future perspectives | International Journal of Antimicrobial Agents | 2020 | 838 |
| 13 | Epidemiology of resistance to antibiotics Links between animals and humans | International Journal of Antimicrobial Agents | 2000 | 824 |
| 14 | Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 | International Journal of Antimicrobial Agents | 2020 | 745 |
| 15 | The epidemiology, diagnosis and treatment of COVID-19 | International Journal of Antimicrobial Agents | 2020 | 697 |
| 16 | The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver | International Journal of Antimicrobial Agents | 2009 | 675 |
| 17 | Introduction to biofilm | International Journal of Antimicrobial Agents | 1999 | 631 |
| 18 | Recommendations to achieve rapid therapeutic teicoplanin plasma concentrations in adult hospitalised patients treated for sepsis | International Journal of Antimicrobial Agents | 2008 | 605 |
| 19 | Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii : Mechanisms and epidemiology | International Journal of Antimicrobial Agents | 2015 | 590 |
| 20 | Alkaloids: An overview of their antibacterial, antibiotic-enhancing and antivirulence activities | International Journal of Antimicrobial Agents | 2014 | 565 |
| 21 | Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV | International Journal of Antimicrobial Agents | 2009 | 517 |
| 22 | The fluoroquinolone antibacterials: past, present and future perspectives | International Journal of Antimicrobial Agents | 2000 | 511 |
| 23 | Lactoferrin: structure, function and applications | International Journal of Antimicrobial Agents | 2009 | 500 |
| 24 | Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods | International Journal of Antimicrobial Agents | 2012 | 488 |
| 25 | Metal oxide nanoparticles as antimicrobial agents: a promise for the future | International Journal of Antimicrobial Agents | 2017 | 487 |
| 26 | Mechanisms of quinolone resistance in Escherichia coli and Salmonella: Recent developments | International Journal of Antimicrobial Agents | 2005 | 477 |
| 27 | Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection | International Journal of Antimicrobial Agents | 2020 | 472 |
| 28 | Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria | International Journal of Antimicrobial Agents | 2005 | 470 |
| 29 | Emergence of resistance to antibacterial agents: the role of quaternary ammonium compounds—a critical review | International Journal of Antimicrobial Agents | 2012 | 467 |
| 30 | Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages | International Journal of Antimicrobial Agents | 2013 | 461 |
| 31 | Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies | International Journal of Antimicrobial Agents | 2020 | 460 |
| 32 | Emerging carbapenemases: a global perspective | International Journal of Antimicrobial Agents | 2010 | 420 |
| 33 | Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections | International Journal of Antimicrobial Agents | 2008 | 411 |
| 34 | Use of antimicrobial agents in veterinary medicine and food animal production | International Journal of Antimicrobial Agents | 2001 | 406 |
| 35 | Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4 | International Journal of Antimicrobial Agents | 2010 | 402 |
| 36 | Antimicrobial peptides in animals and their role in host defences | International Journal of Antimicrobial Agents | 2003 | 397 |
| 37 | Recurrent urinary tract infection in women | International Journal of Antimicrobial Agents | 2001 | 394 |
| 38 | Nosocomial infections by Staphylococcus epidermidis: how a commensal bacterium turns into a pathogen | International Journal of Antimicrobial Agents | 2006 | 375 |
| 39 | Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications | International Journal of Antimicrobial Agents | 2000 | 370 |
| 40 | Chloroquine for the 2019 novel coronavirus SARS-CoV-2 | International Journal of Antimicrobial Agents | 2020 | 366 |
| 41 | Catheter-associated urinary tract infections | International Journal of Antimicrobial Agents | 2001 | 362 |
| 42 | Understanding physician antibiotic prescribing behaviour: a systematic review of qualitative studies | International Journal of Antimicrobial Agents | 2013 | 362 |
| 43 | Animal model pharmacokinetics and pharmacodynamics: a critical review | International Journal of Antimicrobial Agents | 2002 | 361 |
| 44 | Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century | International Journal of Antimicrobial Agents | 2007 | 340 |
| 45 | Antimicrobial activity of spices | International Journal of Antimicrobial Agents | 1999 | 339 |
| 46 | Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter | International Journal of Antimicrobial Agents | 2004 | 338 |
| 47 | Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? | International Journal of Antimicrobial Agents | 2007 | 336 |
| 48 | Antibiotic resistance in staphylococci | International Journal of Antimicrobial Agents | 2000 | 334 |
| 49 | Molecular mechanisms of polymyxin resistance: knowns and unknowns | International Journal of Antimicrobial Agents | 2016 | 326 |
| 50 | Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options | International Journal of Antimicrobial Agents | 2012 | 324 |
